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S
tudies  of  individual  development  and  its  possible 
deterioration have been the concern since the 19th 
century,  when  Etienne  Geoffroy  de  Saint-Hilaire 
(1772–1844)  with  his  pioneer  experiments  opened  the 
door for future experimental teratologists. Later scientists, 
focused on environmental agents which can alter embry-
onic and fetal development, such hyperthermia, malnutri-
tion, pharmaceuticals, microbial toxins etc. Although the 
history of teratology involves many notable scientists, it 
has gained prominence after the big thalidomide tragedy in 
1961. Principles of teratology were proposed later by James 
Wilson in his monograph Environment and Birth Defects 
(Wilson, 1973).
From the relative safety assessment point of view, it is 
essential to identify adverse agents, which can be harmful, 
related also to the development of the organism. The criti-
cal embryofetal developmental stages, when the agents are 
potentially most dangerous, require careful consideration 
as  to  maternal  dosing  regiments.  Much  of  our  present 
knowledge concerning the adverse effects of chemicals on 
mammalian development and particularly on human brain 
development relates to events during the early stages of 
gestation. Gestation is divided into two major periods, the 
embryonic and the fetal period. In humans the embryonic 
period constitutes 20% and the fetal 80% of the whole gesta-
tion period. In animals used frequently in research, such as 
mouse and rat, the opposite is seen: the embryonic period 
constitutes 80% and the fetal period 20% of the gestation. 
In 1963, Werboff and Gottlieb came with the notion that 
chemical substances acting during sensitive prenatal brain 
development may cause behavioral alterations manifested 
in the postnatal period. They were the first to introduced 
the concept of behavioral teratology (Werboff and Gottlieb, 
1963).  Epidemiological  as  well  as  experimental  studies 
in later periods showed that exposure of the developing 
organism to physical factors and/or chemical substances 
can cause not only structural but also functional anomalies. 
Functional maldevelopment of the brain can manifest as 
behavioral, emotional and/or cognitive disorders (Grandjean 
and Landrigan, 2006). Moreover, recent studies confirmed 
that any imbalance in the proper development of individual 
organs may result in their malfunctioning at various levels 
and in turn can result in chronic diseases in adulthood, such 
as diabetes, hypertension, etc.). (Barker, 2003). Not only 
chemical substances but also physical and environmental 
factors, such as insufficient nutrition, hypoxia, and stress, 
represent a serious risk factor for structural and functional 
development of the organism. In many cases, impairment 
of intrauterine development may cause the birth of a seem-
ingly  healthy  individual  with  invisible  stigma  of  future 
health problems. 
Asphyxia and Malnutrition as 
Developmental Disrupters 
The important role of equilibrium of environmental 
factors  during  the  embryofetal  period  is  undisputable. 
Women of reproductive age are increasingly exposed to 
various environmental risk factors, such as prenatal viral 
infections, use of drugs, smoking, hypoxia, birth complica-
tions or stressful life events. Perinatal asphyxia is a major 
determinant of neurological morbidity and mortality in the 
neonatal period, causing long-term neurological complica-
tions, such as motor deficits including cerebral palsy, seizure 
and attention deficit/hyperactivity disorder (ADHD) (Hill 
and Volpe, 1989). The global use of medications that treat 
ADHD nearly tripled from 1993 to 2003 (Scheffler et al., 
2007), suggesting wider understanding of the condition in 
the mental health community, healthcare coverage and the 
launch of ADHD-specific drugs. There is an emerging body 
of evidence correlating psychiatric disorders, schizophrenia 
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in particular, to obstetric complications at the time of birth 
(Brixey et al., 1993; Günther-Genta et al., 1994). While a 
number of such complications have been identified as poten-
tial risk factors for schizophrenia, including breached birth, 
delayed labor, Caesarean (C)- section, or umbilical cord 
prolapse, the exact nature of the perinatal insult remains a 
matter of speculation. However, one consequence common 
to many of these perinatal complications is an episode of 
anoxia to the fetus.
Intrauterine growth restriction (IUGR) occurs when 
abnormal developmental processes prevent cells and tissues 
to grow and/or cause cells to decrease in size. This may hap-
pen when the fetus does not receive the necessary nutrients 
and oxygen needed for growth and development of organs 
and tissues, or because of infection or drug abuse. Although 
some babies are small due to genetics (their parents are 
small),  in  most  cases  IUGR  is  caused  by  other  factors 
(maternal, embryofetal or placental). Recent epidemiologic 
studies report an inverse relationship between birth weight 
and hypertension, indicating that suboptimal fetal environ-
ment may also contribute to increased disease in later life 
(Ojeda et al., 2008). Findings of Costelo et al. (2007) suggest 
that adaptations in the womb optimizing survival under 
adverse conditions can lead to low birth weight and may 
later impair girls’ ability to cope with stress. Their lower 
thresholds for stress-triggered illness may remain latent 
until they “encounter adversities that strain their capacity”.
Experimental Approaches in 
Developmental Toxicology 
In  our  experimental  practice,  we  currently  rely  on 
animal tests to predict the potential for chemicals to cause 
reproductive harm in humans. It has been estimated that 
there are 65 000 chemicals in the general environment 
(Schardein,  1993)  with  hundreds  or  thousands  of  new 
chemicals being added to the environment each year. Only 
a few thousand of these chemicals have been examined for 
potential teratogenicity.
Animal  tests  for  assessing  reproductive  toxicity  are 
designed  to  cover  the  entire  reproductive  cycle,  either 
as a series of tests that evaluate specific segments of the 
life  cycle  (reproduction/fertility,  prenatal  and  postnatal 
development),  or  as  a  single  protocol  (two-generation 
test). However, testing for reproductive toxicity is animal-
intensive. Several alternative methods have been proposed, 
driven by the efforts of 3Rs to replace, reduce and refine 
toxicity testing (Piersma, 1993), i.e. the use of established 
cell lines for developmental toxicity screening or rodent 
whole embryo culture. The usual protocol involves daily 
administration of the test substance to pregnant animals 
during their organogenic period and examination of the 
products of gestation shortly before parturition. Two spe-
cies are required, in practice this is usually the rat and the 
rabbit, and three dosage levels, of which the highest dose 
causes some signs of maternal toxicity. However these tests 
(Segment I–III of reproductive toxicity testing) cover only 
the early period of life up to adulthood. Information on the 
delayed neurobehavioral consequences up to senescence 
is limited to a couple of reports. Therefore it is necessary 
to include in the animal testing also long-term studies or 
use alternative animal models, e.g. senescence-accelerated 
mouse strain (Yagi et al., 1988). Development of further up-
to-date precautionary approaches that recognize the unique 
vulnerability of the developing organism are highly needed 
for testing and control of chemicals, drugs as well as other 
risk factors. 
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